Annovis Bio share price logo

Annovis Bio

NYSE: ANVS

$1.31

-0.02

(-1.50%)

as on

Annovis Bio Stock Performance

as on September 28, 2026 at 2:15 pm IST

  • Day's High

    $1.31
    $1.34

    2.29%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.04
    $5.50
    downward going graph

    20.61%

    Downside

    319.85%

    Upside

    downward going graph

Annovis Bio share price movements today

Previous Close
$1.33
Open
$1.34
Volume
779.2K
Market Cap
$55.9M
Day's Low - High
$1.31 - $1.34
52 Week Low - High
$1.04 - $5.50

Annovis Bio Historical Returns

1 Month Return
-23.84 %
3 Month Return
-23.84 %
1 Year Return
-33.5 %
3 Year Return
-86.02 %
5 Year Return
-96.27 %

Annovis Bio Stock Fundamentals & Key Indicators

Check Annovis Bio market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$55.9M

EPS (TTM)

-1.79

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.73

Industry PE ratio

-2.64

PEG Ratio

0.6467550434554261

EBITDA

-49.1M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-685.96%

Annovis Bio Stock Valuation

Track how Annovis Bio P/E has moved over time to understand its valuation trends.

Annovis Bio in the last 5 years

  • Overview

  • Trends

Lowest (-9.25x)

December 31, 2021

Industry (-2.64x)

December 31, 2025

Today (-2.47x)

December 31, 2025

Highest (-0.00x)

March 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -2.47x

Annovis Bio vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Annovis Bio with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$55.9M-96.27%-0.730.00%0.00%
StrongBuy$43.9B615.18%-23.130.00%0.00%
Neutral$79.4B-48.24%-24.92-12.57%0.00%
StrongBuy$133.4B189.75%30.3886.04%0.00%
Buy$81.1B30.25%18.8284.86%0.47%

Stock Returns calculator for Annovis Bio Stock including INR - Dollar returns

The Annovis Bio stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Annovis Bio investment value today

Current value as on today

₹71,952

Returns

-₹28,048

(-28.05%)

Returns from Annovis Bio Stock

-₹33,503 (-33.5%)

Dollar Impact

₹5,454 (+5.45%)

Analyst Recommendation on Annovis Bio Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Annovis Bio. Average target price of $10.5

Annovis Bio Share Price Target

Get share price movements and forecasts by analysts on Annovis Bio.

What analysts predicted

87.52%UPSIDE

Target Price

$10.5

Current Price

$1.31

Analyzed by

1 Analysts

High

$17

Target

$10.50

Low

$17

Annovis Bio target price $10.5, a slight upside of 87.52% compared to current price of $1.31. According to 1 analysts rating.

Indian Investors' Interest in Annovis Bio Stock

Search interest for Annovis Bio Stock has decreased by -12% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-12% versus previous 30 day period

Annovis Bio Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-14
-7
-7
-4
-6
-6
-7
-9
-18
-14
EBITDA
-14
-1
-3
-12
-5
-6
-7
-9
-17
-14
Interest Expense
-
-
1
0
-
-
-
-
-
1
Depreciation
-
-
-
0
0
0
-
-
-
-
Income Before Tax
-14
-1
-5
-12
-5
-6
-7
-9
-17
-14
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-14
-1
-5
-12
-5
-6
-7
-9
-17
-14
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Annovis Bio Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Mar 2023
Mar 2024
Mar 2025
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
Operating Income
0
0
-1
-6
-14
-25
-45
-26
-29
EBITDA
0
0
0
-
-14
-25
-56
-22
-28
Interest Expense
0
0
-
47
-
-
-
1
-
Depreciation
0
0
1
6
-
-
-
-
-
Income Before Tax
0
0
0
-5
-14
-25
-56
-24
-28
Income Tax Expense
-
0
-
-
-
-
-
-
-
Net Income
0
0
0
-5
-14
-25
-56
-24
-28
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Annovis Bio Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-14
-1
-5
-12
-5
-6
-7
-9
-17
-14
Operating Cash Flow
-9
-7
-3
-3
-8
-5
-3
-8
-9
-21
Investing Cash Flow
-
-
-
-
-
-
-
-
-
-
Financing Cash Flow
-
4
4
11
19
-
1
13
3
26
Change in Cash
-9
-2
0
8
11
-5
-1
4
-5
4

Annovis Bio Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Mar 2023
Mar 2024
Mar 2025
Dec 2025
Net Income
0
0
0
-5
-14
-25
-56
-24
-28
Operating Cash Flow
0
0
0
-3
-9
-17
-39
-21
-25
Investing Cash Flow
-
-
-
-
-
-
-
-
-
Financing Cash Flow
0
0
0
12
46
0
17
26
34
Change in Cash
0
0
0
8
37
-17
-22
4
8

Mutual Funds that own Annovis Bio Stock

Check out the Mutual Funds with significant holdings in Annovis Bio.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
1.983326%
846465
Fidelity Concord Street Trust
0.439173%
187435
Bridgeway Funds, Inc.
0.078673%
33577
VANGUARD VALLEY FORGE FUNDS
0.030912%
13193
VANGUARD INSTITUTIONAL INDEX FUNDS
0.02981%
12723

Global Institutional Holdings in Annovis Bio

Funds
Holdings
Vanguard
3.66%
VANGUARD INDEX FUNDS
1.98%
Fidelity Concord Street Trust
0.44%
iShares
0.24%
Bridgeway Funds, Inc.
0.08%

Insights on Annovis Bio

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, ANVS stock has moved up by 10.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 712.1% return, outperforming this stock by 745.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 98.3% return, outperforming this stock by 184.3%

About Annovis Bio

Annovis Bio, Inc. is a clinical-stage biopharmaceutical company focused on pioneering treatments for neurodegenerative disorders. The firm's flagship drug, Buntanetap, an oral medication, has successfully advanced through Phase 2a clinical trials for Alzheimer's and Parkinson's diseases. This compound is also currently being evaluated in clinical studies for Alzheimer's disease in individuals with Down Syndrome, as well as for various other chronic neurodegenerative conditions. Beyond Buntanetap, Annovis Bio is developing ANVS405 to offer protection against traumatic brain injury and stroke. Additionally, ANVS301 is progressing through Phase I clinical trials, aiming to enhance cognitive capabilities in the later stages of Alzheimer's disease and broader dementia. The company was founded in 2008 and operates out of Berwyn, Pennsylvania.
OrganisationAnnovis Bio
Headquarters101 Lindenwood Drive, Malvern, PA, 19355, US
IndustryBiotechnology
CEOMaria L. Maccecchini
E-voting on sharesClick here to vote

Key Management of Annovis Bio

Name

Title

Dr. Maria L. Maccecchini Ph.D.

Founder, Acting CFO, CEO, President & Executive Director

Dr. Cheng Fang Ph.D.

Chief Scientific Officer

Ms. Eve M. Damiano M.S., RAC

Senior Vice President of Regulatory Operations

Mr. Blake Jensen M.B.A.

Head of Quality

Ms. Hilda Maibach

Senior Vice President of Statistics

FAQs

What is Annovis Bio share price today?

Annovis Bio share price today is $1.31 as on at the close of the market. Annovis Bio share today touched a day high of $1.34 and a low of $1.31.

What is the 52 week high and 52 week low for Annovis Bio share?

Annovis Bio share touched a 52 week high of $5.50 on and a 52 week low of $1.04 on . Annovis Bio stock price today i.e. is closed at $1.31,which is 76.18% down from its 52 week high and 25.96% up from its 52 week low.

What is Annovis Bio's market capitalisation today?

Annovis Bio market capitalisation is $0.00T as on .

How to invest in Annovis Bio Stock (ANVS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Annovis Bio on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Annovis Bio Shares that will get you 1.1450 shares as per Annovis Bio share price of $1.31 per share as on September 28, 2026 at 8:45 am IST.

What is the minimum amount required to buy Annovis Bio Stock (ANVS) from India?

Indian investors can start investing in Annovis Bio (ANVS) shares with as little as ₹95.980003356934 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹959.80 in Annovis Bio stock (as per the Rupee-Dollar exchange rate as on ). Based on Annovis Bio share’s latest price of $1.31 as on September 28, 2026 at 8:45 am IST, you will get 7.6336 shares of Annovis Bio. Learn more about fractional shares .

What are the returns that Annovis Bio has given to Indian investors in the last 5 years?

Annovis Bio stock has given -96.27% share price returns and 29.98% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?